A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and -tapering
From MaRDI portal
Publication:2170396
DOI10.1214/21-AOAS1549zbMATH Open1498.62200WikidataQ114060487 ScholiaQ114060487MaRDI QIDQ2170396FDOQ2170396
Keith M. Diaz, Ying Kuen Cheung, Thevaa Chandereng
Publication date: 5 September 2022
Published in: The Annals of Applied Statistics (Search for Journal in Brave)
Cites Work
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
- Dose-Finding with Two Agents in Phase I Oncology Trials
- A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents
- Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose
- Continual reassessment method for partial ordering
This page was built for publication: A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and \(\epsilon\)-tapering
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2170396)
